Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
22
|
pubmed:dateCreated |
1985-1-2
|
pubmed:abstractText |
X-ray studies on human insulins prepared by semisynthetic and biosynthetic methods have recently been undertaken. Human insulin differs from porcine insulin only at the COOH terminus of the B-chain. The present study reports the crystal structure of 4-zinc human insulin, which is used clinically as a slow-acting preparation. The structure has been refined, using 1.85-A resolution data, to a residual of 0.173. The unit cell is rhombohedral, space group R3, with hexagonal cell constants a = 80.953 and c = 37.636 A, and it is nearly isomorphous with that of 4-zinc porcine insulin. As a result of a conformational change of the first eight residues of the B-chain of molecule 1 from an extended conformation observed in the 2-zinc structure to an alpha-helical one, the coordination around one of the zinc ions on the 3-fold axis has changed, an additional zinc ion in a general position is bound by the hexamer, and additional hydrogen-bonded interactions help stabilize dimer and hexamer formation. Unlike the surface of the 2-zinc insulin hexamer, which possesses a shallow depression containing a zinc ion and its coordinating water molecules, the 4-zinc human insulin hexamer contains a zinc and chloride ion at the bottom of an 8-A tunnel produced by three parallel alpha-helices. These alpha-helices shield the zinc ion from the environment, decreasing the rate of dissociation of the hexamer, and provide an explanation for the slow-acting aspect of the 4-zinc crystalline form.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/6390430-1272390,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6390430-476502,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6390430-513137,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6390430-6363174,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6390430-6370324,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6390430-7011716,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6390430-7024090,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6390430-85300
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0027-8424
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
81
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7093-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6390430-Amino Acid Sequence,
pubmed-meshheading:6390430-Humans,
pubmed-meshheading:6390430-Insulin,
pubmed-meshheading:6390430-Macromolecular Substances,
pubmed-meshheading:6390430-Models, Molecular,
pubmed-meshheading:6390430-Protein Conformation,
pubmed-meshheading:6390430-Structure-Activity Relationship,
pubmed-meshheading:6390430-X-Ray Diffraction,
pubmed-meshheading:6390430-Zinc
|
pubmed:year |
1984
|
pubmed:articleTitle |
Structural stability in the 4-zinc human insulin hexamer.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|